nodes	percent_of_prediction	percent_of_DWPC	metapath
Gadopentetate dimeglumine—PGD—Dacarbazine—skin cancer	0.836	1	CbGbCtD
Gadopentetate dimeglumine—PGD—nipple—skin cancer	0.00188	0.177	CbGeAlD
Gadopentetate dimeglumine—PGD—neck—skin cancer	0.00186	0.175	CbGeAlD
Gadopentetate dimeglumine—PGD—connective tissue—skin cancer	0.00133	0.125	CbGeAlD
Gadopentetate dimeglumine—PGD—skin of body—skin cancer	0.0012	0.113	CbGeAlD
Gadopentetate dimeglumine—PGD—mammalian vulva—skin cancer	0.0011	0.103	CbGeAlD
Gadopentetate dimeglumine—PGD—lymphoid tissue—skin cancer	0.000975	0.0918	CbGeAlD
Gadopentetate dimeglumine—PGD—female reproductive system—skin cancer	0.000941	0.0885	CbGeAlD
Gadopentetate dimeglumine—PGD—head—skin cancer	0.000786	0.0739	CbGeAlD
Gadopentetate dimeglumine—PGD—lymph node—skin cancer	0.00055	0.0518	CbGeAlD
Gadopentetate dimeglumine—Anorexia—Imiquimod—skin cancer	0.000333	0.00217	CcSEcCtD
Gadopentetate dimeglumine—Angina pectoris—Fluorouracil—skin cancer	0.00033	0.00215	CcSEcCtD
Gadopentetate dimeglumine—Phlebitis—Docetaxel—skin cancer	0.000328	0.00214	CcSEcCtD
Gadopentetate dimeglumine—Thrombophlebitis—Docetaxel—skin cancer	0.000327	0.00213	CcSEcCtD
Gadopentetate dimeglumine—Flushing—Bleomycin—skin cancer	0.000324	0.00211	CcSEcCtD
Gadopentetate dimeglumine—Body temperature increased—Vemurafenib—skin cancer	0.000323	0.00211	CcSEcCtD
Gadopentetate dimeglumine—Musculoskeletal discomfort—Imiquimod—skin cancer	0.000318	0.00207	CcSEcCtD
Gadopentetate dimeglumine—Deafness—Docetaxel—skin cancer	0.000316	0.00206	CcSEcCtD
Gadopentetate dimeglumine—Paraesthesia—Imiquimod—skin cancer	0.000313	0.00204	CcSEcCtD
Gadopentetate dimeglumine—Chills—Bleomycin—skin cancer	0.000313	0.00204	CcSEcCtD
Gadopentetate dimeglumine—Dyspnoea—Imiquimod—skin cancer	0.000311	0.00203	CcSEcCtD
Gadopentetate dimeglumine—Somnolence—Imiquimod—skin cancer	0.00031	0.00202	CcSEcCtD
Gadopentetate dimeglumine—Hepatobiliary disease—Temozolomide—skin cancer	0.00031	0.00202	CcSEcCtD
Gadopentetate dimeglumine—Erythema multiforme—Dactinomycin—skin cancer	0.000308	0.002	CcSEcCtD
Gadopentetate dimeglumine—Erythema—Bleomycin—skin cancer	0.000304	0.00198	CcSEcCtD
Gadopentetate dimeglumine—Decreased appetite—Imiquimod—skin cancer	0.000303	0.00197	CcSEcCtD
Gadopentetate dimeglumine—Flushing—Dactinomycin—skin cancer	0.000302	0.00197	CcSEcCtD
Gadopentetate dimeglumine—Hypersensitivity—Vemurafenib—skin cancer	0.000301	0.00196	CcSEcCtD
Gadopentetate dimeglumine—Gastrointestinal disorder—Imiquimod—skin cancer	0.000301	0.00196	CcSEcCtD
Gadopentetate dimeglumine—Fatigue—Imiquimod—skin cancer	0.000301	0.00196	CcSEcCtD
Gadopentetate dimeglumine—Visual disturbance—Docetaxel—skin cancer	0.000299	0.00194	CcSEcCtD
Gadopentetate dimeglumine—Pain—Imiquimod—skin cancer	0.000298	0.00194	CcSEcCtD
Gadopentetate dimeglumine—Acute coronary syndrome—Fluorouracil—skin cancer	0.000298	0.00194	CcSEcCtD
Gadopentetate dimeglumine—Renal impairment—Docetaxel—skin cancer	0.000297	0.00194	CcSEcCtD
Gadopentetate dimeglumine—Myocardial infarction—Fluorouracil—skin cancer	0.000296	0.00193	CcSEcCtD
Gadopentetate dimeglumine—Conjunctivitis—Fluorouracil—skin cancer	0.000294	0.00191	CcSEcCtD
Gadopentetate dimeglumine—Asthenia—Vemurafenib—skin cancer	0.000294	0.00191	CcSEcCtD
Gadopentetate dimeglumine—Chills—Dactinomycin—skin cancer	0.000292	0.0019	CcSEcCtD
Gadopentetate dimeglumine—Urinary tract disorder—Temozolomide—skin cancer	0.000291	0.00189	CcSEcCtD
Gadopentetate dimeglumine—Oedema peripheral—Temozolomide—skin cancer	0.00029	0.00189	CcSEcCtD
Gadopentetate dimeglumine—Pruritus—Vemurafenib—skin cancer	0.000289	0.00188	CcSEcCtD
Gadopentetate dimeglumine—Connective tissue disorder—Temozolomide—skin cancer	0.000289	0.00188	CcSEcCtD
Gadopentetate dimeglumine—Urethral disorder—Temozolomide—skin cancer	0.000288	0.00188	CcSEcCtD
Gadopentetate dimeglumine—Feeling abnormal—Imiquimod—skin cancer	0.000288	0.00187	CcSEcCtD
Gadopentetate dimeglumine—Gastrointestinal pain—Imiquimod—skin cancer	0.000285	0.00186	CcSEcCtD
Gadopentetate dimeglumine—Visual impairment—Temozolomide—skin cancer	0.000284	0.00185	CcSEcCtD
Gadopentetate dimeglumine—Erythema—Dactinomycin—skin cancer	0.000283	0.00184	CcSEcCtD
Gadopentetate dimeglumine—Pain in extremity—Docetaxel—skin cancer	0.000283	0.00184	CcSEcCtD
Gadopentetate dimeglumine—Diarrhoea—Vemurafenib—skin cancer	0.00028	0.00182	CcSEcCtD
Gadopentetate dimeglumine—Migraine—Docetaxel—skin cancer	0.000278	0.00181	CcSEcCtD
Gadopentetate dimeglumine—Erythema multiforme—Temozolomide—skin cancer	0.000278	0.00181	CcSEcCtD
Gadopentetate dimeglumine—Urticaria—Imiquimod—skin cancer	0.000277	0.0018	CcSEcCtD
Gadopentetate dimeglumine—Body temperature increased—Imiquimod—skin cancer	0.000276	0.0018	CcSEcCtD
Gadopentetate dimeglumine—Abdominal pain—Imiquimod—skin cancer	0.000276	0.0018	CcSEcCtD
Gadopentetate dimeglumine—Eye disorder—Temozolomide—skin cancer	0.000275	0.00179	CcSEcCtD
Gadopentetate dimeglumine—Tinnitus—Temozolomide—skin cancer	0.000274	0.00179	CcSEcCtD
Gadopentetate dimeglumine—Malaise—Bleomycin—skin cancer	0.000274	0.00178	CcSEcCtD
Gadopentetate dimeglumine—Flushing—Temozolomide—skin cancer	0.000273	0.00178	CcSEcCtD
Gadopentetate dimeglumine—Cardiac disorder—Temozolomide—skin cancer	0.000273	0.00178	CcSEcCtD
Gadopentetate dimeglumine—Rhinitis—Fluorouracil—skin cancer	0.000272	0.00177	CcSEcCtD
Gadopentetate dimeglumine—Dizziness—Vemurafenib—skin cancer	0.000271	0.00176	CcSEcCtD
Gadopentetate dimeglumine—Angiopathy—Temozolomide—skin cancer	0.000267	0.00174	CcSEcCtD
Gadopentetate dimeglumine—Immune system disorder—Temozolomide—skin cancer	0.000266	0.00173	CcSEcCtD
Gadopentetate dimeglumine—Mediastinal disorder—Temozolomide—skin cancer	0.000265	0.00173	CcSEcCtD
Gadopentetate dimeglumine—Cough—Bleomycin—skin cancer	0.000265	0.00173	CcSEcCtD
Gadopentetate dimeglumine—Chills—Temozolomide—skin cancer	0.000264	0.00172	CcSEcCtD
Gadopentetate dimeglumine—Vomiting—Vemurafenib—skin cancer	0.00026	0.00169	CcSEcCtD
Gadopentetate dimeglumine—Chest pain—Bleomycin—skin cancer	0.000259	0.00168	CcSEcCtD
Gadopentetate dimeglumine—Abdominal pain upper—Docetaxel—skin cancer	0.000258	0.00168	CcSEcCtD
Gadopentetate dimeglumine—Rash—Vemurafenib—skin cancer	0.000258	0.00168	CcSEcCtD
Gadopentetate dimeglumine—Mental disorder—Temozolomide—skin cancer	0.000258	0.00168	CcSEcCtD
Gadopentetate dimeglumine—Dermatitis—Vemurafenib—skin cancer	0.000258	0.00168	CcSEcCtD
Gadopentetate dimeglumine—Hypersensitivity—Imiquimod—skin cancer	0.000257	0.00167	CcSEcCtD
Gadopentetate dimeglumine—Headache—Vemurafenib—skin cancer	0.000256	0.00167	CcSEcCtD
Gadopentetate dimeglumine—Erythema—Temozolomide—skin cancer	0.000256	0.00167	CcSEcCtD
Gadopentetate dimeglumine—Malaise—Dactinomycin—skin cancer	0.000255	0.00166	CcSEcCtD
Gadopentetate dimeglumine—Toxic epidermal necrolysis—Docetaxel—skin cancer	0.000255	0.00166	CcSEcCtD
Gadopentetate dimeglumine—Nasopharyngitis—Docetaxel—skin cancer	0.000253	0.00165	CcSEcCtD
Gadopentetate dimeglumine—Dysgeusia—Temozolomide—skin cancer	0.000251	0.00163	CcSEcCtD
Gadopentetate dimeglumine—Asthenia—Imiquimod—skin cancer	0.00025	0.00163	CcSEcCtD
Gadopentetate dimeglumine—Confusional state—Bleomycin—skin cancer	0.00025	0.00163	CcSEcCtD
Gadopentetate dimeglumine—Anaphylactic shock—Bleomycin—skin cancer	0.000248	0.00161	CcSEcCtD
Gadopentetate dimeglumine—Back pain—Temozolomide—skin cancer	0.000248	0.00161	CcSEcCtD
Gadopentetate dimeglumine—Pruritus—Imiquimod—skin cancer	0.000247	0.00161	CcSEcCtD
Gadopentetate dimeglumine—Nausea—Vemurafenib—skin cancer	0.000243	0.00158	CcSEcCtD
Gadopentetate dimeglumine—Arrhythmia—Fluorouracil—skin cancer	0.000242	0.00158	CcSEcCtD
Gadopentetate dimeglumine—Bronchospasm—Docetaxel—skin cancer	0.00024	0.00157	CcSEcCtD
Gadopentetate dimeglumine—Tremor—Temozolomide—skin cancer	0.00024	0.00156	CcSEcCtD
Gadopentetate dimeglumine—Diarrhoea—Imiquimod—skin cancer	0.000239	0.00155	CcSEcCtD
Gadopentetate dimeglumine—Angina pectoris—Docetaxel—skin cancer	0.000238	0.00155	CcSEcCtD
Gadopentetate dimeglumine—Anorexia—Bleomycin—skin cancer	0.000236	0.00154	CcSEcCtD
Gadopentetate dimeglumine—Erythema—Fluorouracil—skin cancer	0.000236	0.00154	CcSEcCtD
Gadopentetate dimeglumine—Agitation—Temozolomide—skin cancer	0.000235	0.00153	CcSEcCtD
Gadopentetate dimeglumine—Angioedema—Temozolomide—skin cancer	0.000234	0.00152	CcSEcCtD
Gadopentetate dimeglumine—Hypotension—Bleomycin—skin cancer	0.000232	0.00151	CcSEcCtD
Gadopentetate dimeglumine—Malaise—Temozolomide—skin cancer	0.000231	0.0015	CcSEcCtD
Gadopentetate dimeglumine—Dizziness—Imiquimod—skin cancer	0.000231	0.0015	CcSEcCtD
Gadopentetate dimeglumine—Musculoskeletal discomfort—Bleomycin—skin cancer	0.000226	0.00147	CcSEcCtD
Gadopentetate dimeglumine—Cough—Temozolomide—skin cancer	0.000224	0.00146	CcSEcCtD
Gadopentetate dimeglumine—Paraesthesia—Bleomycin—skin cancer	0.000223	0.00145	CcSEcCtD
Gadopentetate dimeglumine—Convulsion—Temozolomide—skin cancer	0.000222	0.00145	CcSEcCtD
Gadopentetate dimeglumine—Vomiting—Imiquimod—skin cancer	0.000222	0.00144	CcSEcCtD
Gadopentetate dimeglumine—Hypertension—Temozolomide—skin cancer	0.000221	0.00144	CcSEcCtD
Gadopentetate dimeglumine—Dyspnoea—Bleomycin—skin cancer	0.000221	0.00144	CcSEcCtD
Gadopentetate dimeglumine—Anorexia—Dactinomycin—skin cancer	0.00022	0.00143	CcSEcCtD
Gadopentetate dimeglumine—Rash—Imiquimod—skin cancer	0.00022	0.00143	CcSEcCtD
Gadopentetate dimeglumine—Dermatitis—Imiquimod—skin cancer	0.00022	0.00143	CcSEcCtD
Gadopentetate dimeglumine—Headache—Imiquimod—skin cancer	0.000219	0.00142	CcSEcCtD
Gadopentetate dimeglumine—Arthralgia—Temozolomide—skin cancer	0.000218	0.00142	CcSEcCtD
Gadopentetate dimeglumine—Anxiety—Temozolomide—skin cancer	0.000217	0.00142	CcSEcCtD
Gadopentetate dimeglumine—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—skin cancer	0.000217	0.00141	CcSEcCtD
Gadopentetate dimeglumine—Decreased appetite—Bleomycin—skin cancer	0.000215	0.0014	CcSEcCtD
Gadopentetate dimeglumine—Acute coronary syndrome—Docetaxel—skin cancer	0.000215	0.0014	CcSEcCtD
Gadopentetate dimeglumine—Renal failure—Docetaxel—skin cancer	0.000214	0.0014	CcSEcCtD
Gadopentetate dimeglumine—Myocardial infarction—Docetaxel—skin cancer	0.000214	0.00139	CcSEcCtD
Gadopentetate dimeglumine—Dry mouth—Temozolomide—skin cancer	0.000213	0.00139	CcSEcCtD
Gadopentetate dimeglumine—Pain—Bleomycin—skin cancer	0.000212	0.00138	CcSEcCtD
Gadopentetate dimeglumine—Conjunctivitis—Docetaxel—skin cancer	0.000212	0.00138	CcSEcCtD
Gadopentetate dimeglumine—Confusional state—Temozolomide—skin cancer	0.000211	0.00137	CcSEcCtD
Gadopentetate dimeglumine—Musculoskeletal discomfort—Dactinomycin—skin cancer	0.000211	0.00137	CcSEcCtD
Gadopentetate dimeglumine—Anaphylactic shock—Temozolomide—skin cancer	0.000209	0.00136	CcSEcCtD
Gadopentetate dimeglumine—Nausea—Imiquimod—skin cancer	0.000207	0.00135	CcSEcCtD
Gadopentetate dimeglumine—Hepatobiliary disease—Docetaxel—skin cancer	0.000206	0.00134	CcSEcCtD
Gadopentetate dimeglumine—Nervous system disorder—Temozolomide—skin cancer	0.000205	0.00133	CcSEcCtD
Gadopentetate dimeglumine—Convulsion—Fluorouracil—skin cancer	0.000205	0.00133	CcSEcCtD
Gadopentetate dimeglumine—Feeling abnormal—Bleomycin—skin cancer	0.000204	0.00133	CcSEcCtD
Gadopentetate dimeglumine—Skin disorder—Temozolomide—skin cancer	0.000203	0.00132	CcSEcCtD
Gadopentetate dimeglumine—Hyperhidrosis—Temozolomide—skin cancer	0.000202	0.00132	CcSEcCtD
Gadopentetate dimeglumine—Chest pain—Fluorouracil—skin cancer	0.000201	0.00131	CcSEcCtD
Gadopentetate dimeglumine—Decreased appetite—Dactinomycin—skin cancer	0.000201	0.00131	CcSEcCtD
Gadopentetate dimeglumine—Fatigue—Dactinomycin—skin cancer	0.000199	0.0013	CcSEcCtD
Gadopentetate dimeglumine—Anorexia—Temozolomide—skin cancer	0.000199	0.0013	CcSEcCtD
Gadopentetate dimeglumine—Pain—Dactinomycin—skin cancer	0.000198	0.00129	CcSEcCtD
Gadopentetate dimeglumine—Urticaria—Bleomycin—skin cancer	0.000197	0.00128	CcSEcCtD
Gadopentetate dimeglumine—Rhinitis—Docetaxel—skin cancer	0.000196	0.00128	CcSEcCtD
Gadopentetate dimeglumine—Body temperature increased—Bleomycin—skin cancer	0.000196	0.00128	CcSEcCtD
Gadopentetate dimeglumine—Confusional state—Fluorouracil—skin cancer	0.000194	0.00126	CcSEcCtD
Gadopentetate dimeglumine—Urinary tract disorder—Docetaxel—skin cancer	0.000193	0.00126	CcSEcCtD
Gadopentetate dimeglumine—Oedema peripheral—Docetaxel—skin cancer	0.000193	0.00126	CcSEcCtD
Gadopentetate dimeglumine—Anaphylactic shock—Fluorouracil—skin cancer	0.000193	0.00125	CcSEcCtD
Gadopentetate dimeglumine—Connective tissue disorder—Docetaxel—skin cancer	0.000192	0.00125	CcSEcCtD
Gadopentetate dimeglumine—Urethral disorder—Docetaxel—skin cancer	0.000192	0.00125	CcSEcCtD
Gadopentetate dimeglumine—Feeling abnormal—Dactinomycin—skin cancer	0.00019	0.00124	CcSEcCtD
Gadopentetate dimeglumine—Musculoskeletal discomfort—Temozolomide—skin cancer	0.00019	0.00124	CcSEcCtD
Gadopentetate dimeglumine—Gastrointestinal pain—Dactinomycin—skin cancer	0.000189	0.00123	CcSEcCtD
Gadopentetate dimeglumine—Nervous system disorder—Fluorouracil—skin cancer	0.000189	0.00123	CcSEcCtD
Gadopentetate dimeglumine—Visual impairment—Docetaxel—skin cancer	0.000189	0.00123	CcSEcCtD
Gadopentetate dimeglumine—Tachycardia—Fluorouracil—skin cancer	0.000188	0.00122	CcSEcCtD
Gadopentetate dimeglumine—Paraesthesia—Temozolomide—skin cancer	0.000188	0.00122	CcSEcCtD
Gadopentetate dimeglumine—Dyspnoea—Temozolomide—skin cancer	0.000186	0.00121	CcSEcCtD
Gadopentetate dimeglumine—Somnolence—Temozolomide—skin cancer	0.000186	0.00121	CcSEcCtD
Gadopentetate dimeglumine—Erythema multiforme—Docetaxel—skin cancer	0.000185	0.0012	CcSEcCtD
Gadopentetate dimeglumine—Anorexia—Fluorouracil—skin cancer	0.000184	0.0012	CcSEcCtD
Gadopentetate dimeglumine—Eye disorder—Docetaxel—skin cancer	0.000183	0.00119	CcSEcCtD
Gadopentetate dimeglumine—Abdominal pain—Dactinomycin—skin cancer	0.000183	0.00119	CcSEcCtD
Gadopentetate dimeglumine—Body temperature increased—Dactinomycin—skin cancer	0.000183	0.00119	CcSEcCtD
Gadopentetate dimeglumine—Hypersensitivity—Bleomycin—skin cancer	0.000183	0.00119	CcSEcCtD
Gadopentetate dimeglumine—Decreased appetite—Temozolomide—skin cancer	0.000182	0.00118	CcSEcCtD
Gadopentetate dimeglumine—Flushing—Docetaxel—skin cancer	0.000182	0.00118	CcSEcCtD
Gadopentetate dimeglumine—Cardiac disorder—Docetaxel—skin cancer	0.000182	0.00118	CcSEcCtD
Gadopentetate dimeglumine—Gastrointestinal disorder—Temozolomide—skin cancer	0.000181	0.00118	CcSEcCtD
Gadopentetate dimeglumine—Fatigue—Temozolomide—skin cancer	0.00018	0.00117	CcSEcCtD
Gadopentetate dimeglumine—Hypotension—Fluorouracil—skin cancer	0.00018	0.00117	CcSEcCtD
Gadopentetate dimeglumine—Constipation—Temozolomide—skin cancer	0.000179	0.00116	CcSEcCtD
Gadopentetate dimeglumine—Pain—Temozolomide—skin cancer	0.000179	0.00116	CcSEcCtD
Gadopentetate dimeglumine—Asthenia—Bleomycin—skin cancer	0.000178	0.00116	CcSEcCtD
Gadopentetate dimeglumine—Angiopathy—Docetaxel—skin cancer	0.000178	0.00116	CcSEcCtD
Gadopentetate dimeglumine—Immune system disorder—Docetaxel—skin cancer	0.000177	0.00115	CcSEcCtD
Gadopentetate dimeglumine—Mediastinal disorder—Docetaxel—skin cancer	0.000176	0.00115	CcSEcCtD
Gadopentetate dimeglumine—Chills—Docetaxel—skin cancer	0.000176	0.00114	CcSEcCtD
Gadopentetate dimeglumine—Musculoskeletal discomfort—Fluorouracil—skin cancer	0.000176	0.00114	CcSEcCtD
Gadopentetate dimeglumine—Pruritus—Bleomycin—skin cancer	0.000175	0.00114	CcSEcCtD
Gadopentetate dimeglumine—Arrhythmia—Docetaxel—skin cancer	0.000175	0.00114	CcSEcCtD
Gadopentetate dimeglumine—Paraesthesia—Fluorouracil—skin cancer	0.000173	0.00113	CcSEcCtD
Gadopentetate dimeglumine—Feeling abnormal—Temozolomide—skin cancer	0.000172	0.00112	CcSEcCtD
Gadopentetate dimeglumine—Dyspnoea—Fluorouracil—skin cancer	0.000172	0.00112	CcSEcCtD
Gadopentetate dimeglumine—Mental disorder—Docetaxel—skin cancer	0.000171	0.00112	CcSEcCtD
Gadopentetate dimeglumine—Somnolence—Fluorouracil—skin cancer	0.000171	0.00111	CcSEcCtD
Gadopentetate dimeglumine—Gastrointestinal pain—Temozolomide—skin cancer	0.000171	0.00111	CcSEcCtD
Gadopentetate dimeglumine—Erythema—Docetaxel—skin cancer	0.00017	0.00111	CcSEcCtD
Gadopentetate dimeglumine—Hypersensitivity—Dactinomycin—skin cancer	0.00017	0.00111	CcSEcCtD
Gadopentetate dimeglumine—Decreased appetite—Fluorouracil—skin cancer	0.000167	0.00109	CcSEcCtD
Gadopentetate dimeglumine—Dysgeusia—Docetaxel—skin cancer	0.000167	0.00109	CcSEcCtD
Gadopentetate dimeglumine—Gastrointestinal disorder—Fluorouracil—skin cancer	0.000166	0.00108	CcSEcCtD
Gadopentetate dimeglumine—Urticaria—Temozolomide—skin cancer	0.000166	0.00108	CcSEcCtD
Gadopentetate dimeglumine—Asthenia—Dactinomycin—skin cancer	0.000166	0.00108	CcSEcCtD
Gadopentetate dimeglumine—Abdominal pain—Temozolomide—skin cancer	0.000165	0.00108	CcSEcCtD
Gadopentetate dimeglumine—Body temperature increased—Temozolomide—skin cancer	0.000165	0.00108	CcSEcCtD
Gadopentetate dimeglumine—Back pain—Docetaxel—skin cancer	0.000165	0.00107	CcSEcCtD
Gadopentetate dimeglumine—Pain—Fluorouracil—skin cancer	0.000165	0.00107	CcSEcCtD
Gadopentetate dimeglumine—Feeling abnormal—Fluorouracil—skin cancer	0.000159	0.00103	CcSEcCtD
Gadopentetate dimeglumine—Diarrhoea—Dactinomycin—skin cancer	0.000158	0.00103	CcSEcCtD
Gadopentetate dimeglumine—Vomiting—Bleomycin—skin cancer	0.000158	0.00103	CcSEcCtD
Gadopentetate dimeglumine—Rash—Bleomycin—skin cancer	0.000156	0.00102	CcSEcCtD
Gadopentetate dimeglumine—Dermatitis—Bleomycin—skin cancer	0.000156	0.00102	CcSEcCtD
Gadopentetate dimeglumine—Hypersensitivity—Temozolomide—skin cancer	0.000154	0.001	CcSEcCtD
Gadopentetate dimeglumine—Urticaria—Fluorouracil—skin cancer	0.000153	0.000996	CcSEcCtD
Gadopentetate dimeglumine—Syncope—Docetaxel—skin cancer	0.000153	0.000995	CcSEcCtD
Gadopentetate dimeglumine—Body temperature increased—Fluorouracil—skin cancer	0.000152	0.000991	CcSEcCtD
Gadopentetate dimeglumine—Asthenia—Temozolomide—skin cancer	0.00015	0.000977	CcSEcCtD
Gadopentetate dimeglumine—Loss of consciousness—Docetaxel—skin cancer	0.00015	0.000975	CcSEcCtD
Gadopentetate dimeglumine—Cough—Docetaxel—skin cancer	0.000149	0.000968	CcSEcCtD
Gadopentetate dimeglumine—Pruritus—Temozolomide—skin cancer	0.000148	0.000963	CcSEcCtD
Gadopentetate dimeglumine—Convulsion—Docetaxel—skin cancer	0.000148	0.000961	CcSEcCtD
Gadopentetate dimeglumine—Nausea—Bleomycin—skin cancer	0.000147	0.000959	CcSEcCtD
Gadopentetate dimeglumine—Hypertension—Docetaxel—skin cancer	0.000147	0.000958	CcSEcCtD
Gadopentetate dimeglumine—Vomiting—Dactinomycin—skin cancer	0.000147	0.000957	CcSEcCtD
Gadopentetate dimeglumine—Rash—Dactinomycin—skin cancer	0.000146	0.000949	CcSEcCtD
Gadopentetate dimeglumine—Chest pain—Docetaxel—skin cancer	0.000145	0.000944	CcSEcCtD
Gadopentetate dimeglumine—Arthralgia—Docetaxel—skin cancer	0.000145	0.000944	CcSEcCtD
Gadopentetate dimeglumine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—skin cancer	0.000144	0.000938	CcSEcCtD
Gadopentetate dimeglumine—Diarrhoea—Temozolomide—skin cancer	0.000143	0.000931	CcSEcCtD
Gadopentetate dimeglumine—Hypersensitivity—Fluorouracil—skin cancer	0.000142	0.000924	CcSEcCtD
Gadopentetate dimeglumine—Dry mouth—Docetaxel—skin cancer	0.000142	0.000924	CcSEcCtD
Gadopentetate dimeglumine—Confusional state—Docetaxel—skin cancer	0.00014	0.000913	CcSEcCtD
Gadopentetate dimeglumine—Anaphylactic shock—Docetaxel—skin cancer	0.000139	0.000905	CcSEcCtD
Gadopentetate dimeglumine—Dizziness—Temozolomide—skin cancer	0.000138	0.0009	CcSEcCtD
Gadopentetate dimeglumine—Nausea—Dactinomycin—skin cancer	0.000137	0.000894	CcSEcCtD
Gadopentetate dimeglumine—Shock—Docetaxel—skin cancer	0.000137	0.000891	CcSEcCtD
Gadopentetate dimeglumine—Nervous system disorder—Docetaxel—skin cancer	0.000136	0.000888	CcSEcCtD
Gadopentetate dimeglumine—Pruritus—Fluorouracil—skin cancer	0.000136	0.000887	CcSEcCtD
Gadopentetate dimeglumine—Tachycardia—Docetaxel—skin cancer	0.000136	0.000883	CcSEcCtD
Gadopentetate dimeglumine—Skin disorder—Docetaxel—skin cancer	0.000135	0.000879	CcSEcCtD
Gadopentetate dimeglumine—Vomiting—Temozolomide—skin cancer	0.000133	0.000865	CcSEcCtD
Gadopentetate dimeglumine—Anorexia—Docetaxel—skin cancer	0.000133	0.000863	CcSEcCtD
Gadopentetate dimeglumine—Rash—Temozolomide—skin cancer	0.000132	0.000858	CcSEcCtD
Gadopentetate dimeglumine—Diarrhoea—Fluorouracil—skin cancer	0.000132	0.000858	CcSEcCtD
Gadopentetate dimeglumine—Dermatitis—Temozolomide—skin cancer	0.000132	0.000857	CcSEcCtD
Gadopentetate dimeglumine—Headache—Temozolomide—skin cancer	0.000131	0.000853	CcSEcCtD
Gadopentetate dimeglumine—Hypotension—Docetaxel—skin cancer	0.00013	0.000846	CcSEcCtD
Gadopentetate dimeglumine—Dizziness—Fluorouracil—skin cancer	0.000127	0.000829	CcSEcCtD
Gadopentetate dimeglumine—Musculoskeletal discomfort—Docetaxel—skin cancer	0.000127	0.000825	CcSEcCtD
Gadopentetate dimeglumine—Paraesthesia—Docetaxel—skin cancer	0.000125	0.000813	CcSEcCtD
Gadopentetate dimeglumine—Nausea—Temozolomide—skin cancer	0.000124	0.000809	CcSEcCtD
Gadopentetate dimeglumine—Dyspnoea—Docetaxel—skin cancer	0.000124	0.000807	CcSEcCtD
Gadopentetate dimeglumine—Somnolence—Docetaxel—skin cancer	0.000124	0.000805	CcSEcCtD
Gadopentetate dimeglumine—Vomiting—Fluorouracil—skin cancer	0.000122	0.000797	CcSEcCtD
Gadopentetate dimeglumine—Rash—Fluorouracil—skin cancer	0.000121	0.000791	CcSEcCtD
Gadopentetate dimeglumine—Dermatitis—Fluorouracil—skin cancer	0.000121	0.00079	CcSEcCtD
Gadopentetate dimeglumine—Decreased appetite—Docetaxel—skin cancer	0.000121	0.000787	CcSEcCtD
Gadopentetate dimeglumine—Headache—Fluorouracil—skin cancer	0.000121	0.000786	CcSEcCtD
Gadopentetate dimeglumine—Gastrointestinal disorder—Docetaxel—skin cancer	0.00012	0.000782	CcSEcCtD
Gadopentetate dimeglumine—Fatigue—Docetaxel—skin cancer	0.00012	0.00078	CcSEcCtD
Gadopentetate dimeglumine—Pain—Docetaxel—skin cancer	0.000119	0.000774	CcSEcCtD
Gadopentetate dimeglumine—Constipation—Docetaxel—skin cancer	0.000119	0.000774	CcSEcCtD
Gadopentetate dimeglumine—Feeling abnormal—Docetaxel—skin cancer	0.000115	0.000746	CcSEcCtD
Gadopentetate dimeglumine—Nausea—Fluorouracil—skin cancer	0.000114	0.000745	CcSEcCtD
Gadopentetate dimeglumine—Gastrointestinal pain—Docetaxel—skin cancer	0.000114	0.00074	CcSEcCtD
Gadopentetate dimeglumine—Body temperature increased—Docetaxel—skin cancer	0.00011	0.000716	CcSEcCtD
Gadopentetate dimeglumine—Abdominal pain—Docetaxel—skin cancer	0.00011	0.000716	CcSEcCtD
Gadopentetate dimeglumine—Hypersensitivity—Docetaxel—skin cancer	0.000102	0.000667	CcSEcCtD
Gadopentetate dimeglumine—Asthenia—Docetaxel—skin cancer	9.98e-05	0.000649	CcSEcCtD
Gadopentetate dimeglumine—Pruritus—Docetaxel—skin cancer	9.84e-05	0.00064	CcSEcCtD
Gadopentetate dimeglumine—Diarrhoea—Docetaxel—skin cancer	9.51e-05	0.000619	CcSEcCtD
Gadopentetate dimeglumine—Dizziness—Docetaxel—skin cancer	9.19e-05	0.000599	CcSEcCtD
Gadopentetate dimeglumine—Vomiting—Docetaxel—skin cancer	8.84e-05	0.000576	CcSEcCtD
Gadopentetate dimeglumine—Rash—Docetaxel—skin cancer	8.77e-05	0.000571	CcSEcCtD
Gadopentetate dimeglumine—Dermatitis—Docetaxel—skin cancer	8.76e-05	0.00057	CcSEcCtD
Gadopentetate dimeglumine—Headache—Docetaxel—skin cancer	8.71e-05	0.000567	CcSEcCtD
Gadopentetate dimeglumine—Nausea—Docetaxel—skin cancer	8.26e-05	0.000538	CcSEcCtD
